Abstract
Analysis of several inbred rat strains has led us to hypothesize that HPA axis abnormalities may contribute, in part, to susceptibility to both autoimmune disease and addiction. In this article we review the evidence for this hypothesis and describe our ongoing efforts to genetically characterize these traits. We have mapped the locations of 23 loci that regulate autoimmune disease in rats, and are currently constructing QTL congenic lines in which a genomic region from the resistant strain is transferred to the susceptible strain or vice versa. These QTL congenic lines will be valuable to test whether genes encoding autoimmune regulation also control neuroendocrine traits. Further genetic dissection and identification of the underlying genes will be necessary to infer a mechanistic link between autoimmune and neuroendocrine traits.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
D.A. Carson, Genetic factors in the etiology and pathogenesis of autoimmunity, FASEB J. 6:2800 (1992).
R.L. Wilder, Neuroendocrine-immune system interactions and autoimmunity, Ann. Rev. Immunol. 13:307 (1995).
R.L. Wilder, Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis, J. Rheumato.l Suppl. 44:10 (1996).
R.L. Wilder, R.L. and I.J. Elenkov, Hormonal regulation of tumor necrosis factor-alpha, interleukin-12 and nterleukin-10 production by activated macrophages. A disease-modifying mechanism in rheumatoid arthritis and systemic lupus erythematosus? Ann. N.Y. Acad. Sci. 876:14 (1999).
R.L Wilder, E.F. Remmers, Y. Kawahito, P.S. Gulko, G.W. Cannon, and MM. Griffiths, Genetic factors regulating experimental arthritis in mice and rats., in: Current Directions in Autoimmunity; Vol 1: Genes and Genetics of Autoimmunity. AN. Theophilopoulos, ed., Karger, Basel (1999).
M.M. Griffiths, J.A. Encinas, E.F. Remmers, V.K. Kuchroo, and R.L. Wilder, Mapping autoimmunity genes, Curr. Opin. Immunol. 11:689(1999).
R.L. Wilder, R.L., Hormones and autoimmunity: animal models of arthritis. Baillieres Clin. Rheumatol. 10:259 (1996).
B. Joe and R.L. Wilder, Animal models of rheumatoid arthritis, Molecular Medicine Today, 5:367 (1999).
I. Dahlman, L. Jacobsson, A. Glaser, J.C. Lorentzen, M. Andersson, H. Luthman and T. Olsson, Genome-wide linkage analysis of chronic relapsing experimental autoimmune encephalomyelitis in the rat identifies a major susceptibility locus on chromosome 9. J. Immunol. 162:2581 (1999).
D.C. Lenz, N.A Wolf, and R.H. Swanborg, Strain variation in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis. J. Immunol. 163:1763 (1999).
I. Dahlman, J.C. Lorentzen, K.L. de Graaf, A. Stefferl, C. Linington, H. Luthman, and T. Olsson, Quantitative trait loci disposing for both experimental arthritis and encephalomyelitis in the DA rat; impact on severity of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis and antibody isotype pattern. Eur. J. Immunol. 28:2188 (1998).
M.K. Storch, A. Stefferl, U. Brehm, R. Weissert, E. Wallstrom, M. Kerschensteiner, T. Olsson, C. Linington, and H. Lassmann, Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8:681 (1998).
R.R. Caspi, C.C. Chan, Y. Fujino, S. Oddo, F. Najafian, S. Bahmanyar, H. Heremans, R.L. Wilder, and B. Wiggert, Genetic factors in susceptibility and resistance to experimental autoimmune uveoretinitis, Curr. Eye Res. 11:81 (1992).
R. Weissert, E. Wallstrom, M.K. Storch, A. Stefferl, J. Lorentzen, H. Lassmann, C. Linington, and T. Olsson, MHC haplotype-dependent regulation of MOG-induced EAE in rats, J. Clin. Invest. 102:1265 (1998).
A. Stefferl, U. Brehm, M Storch, D. Lambracht-Washington, C. Bourquin, K. Wonigeit, H. Lassmann, and C. Linington, Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the “resistant” Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. J. Immunol. 163:40 (1999).
E.S. Brodkin, W.A Carlezon, Jr., C.N. Haile, T.A. Kosten, G.R. Heninger, and E.J. Nestler, Genetic analysis of behavioral, neuroendocrine, and biochemical parameters in inbred rodents: initial studies in Lewis and Fischer 344 rats and in A/J and C57BL/6J mice, Brain Res. 805:55 (1998).
E.S. Brodkin, T.A. Kosten, C.N. Haile, G.R. Heninger, W.A. Carlezon, Jr., P. Jatlow, E.F. Remmers, R.L. Wilder & E.J. Nestler, Dark Agouti and Fischer 344 rats: differential behavioral responses to morphine and biochemical differences in the ventral tegmental area. Neuroscience. 88:1307 (1999).
A.C. Griffin and C.C. Whitacre, Sex and strain differences in the circadian rhythm fluctuation of endocrine and immune function in the rat: implications for rodent models of autoimmune disease, J. Neuroimmunol. 35:53 (1991).
F.S. Dhabhar, B.S. McEwen, and R.L. Spencer, Stress response, adrenal steroid receptor levels and corticosteroid-binding globulin levels—a comparison between Sprague-Dawley, Fischer 344 and Lewis rats, Brain Res. 616:89 (1993).
M.S. Oitzl, AD. van Haarst, W. Sutanto, and E.R. de Kloet, Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis, Psychoneuroendocrinology 20:655 (1995).
D. Morgan, C.D, Cook, and M.J. Picker, Sensitivity to the discriminative stimulus and antinociceptive effects of mu opioids: role of strain of rat, stimulus intensity, and intrinsic efficacy at the mu opioid receptor, J. Pharmacol. Exp. Ther. 289:965 (1999).
J.S. Walker, C.R. Howlett, and V. Nayanar Anti-inflammatory effects of kappa-opioids in adjuvant arthritis, Life Sci. 57:371 (1995).
W. Binder and J.S. Walker, Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis, Br. J. Pharmacol. 124:647 (1998).
J. Antic, T, Vasiljevic, S. Stanojevic, V, Vujic, V. Kovacevic-Jovanovic, D. Djergovic, C. Miljevic, B.M. Markovic, and J. Radulovic, Suppression of adjuvant arthritis by kappa-opioid receptor agonist: effect of route of administration and strain differences, Immunopharmacology 34:105 (1996).
B.D. Jankovic and D. Marie, Enkephalins and autoimmunity: differential effect of methionine-enkephalin on experimental allergic encephalomyelitis in Wistar and Lewis rats, J. Neurosci. Res. 18:88 (1987).
X. Guitart, J.H. Kogan, M. Berhow, R.Z. Terwilliger, G.K. Aghajanian, and E.J. Nestler, Lewis and Fischer at strains display differences in biochemical, electrophysiological and behavioral parameters: studies in the nucleus accumbens and locus coeruleus of drug naive and morphine-treated animals, Brain Res. 611:7(1993).
S. Martin, J. Manzanares, J. Corchero, C. Garcia-Lecumberri, J.A. Crespo, J.A. Fuentes, and E. Ambrosio, Differential basal proenkephalin gene expression in dorsal striatum and nucleus accumbens, and vulnerability to morphine self-administration in Fischer 344 and Lewis rats. Brain Res. 821:350 (1999).
E.M. Sternberg, W.S. Young 3d, R. Bernardini, A.E. Calogero, G.P. Chrousos, P.W. Gold, and R.L. Wilder, A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. U.S.A. 86:4771 (1989).
T. Suzuki, F.R. George, and R.A. Meisch, Differential establishment and maintenance of oral ethanol reinforced behavior in Lewis and Fischer 344 inbred rat strains. J. Pharmacol. Exp. Ther. 245:164 (1988).
T.A. Kosten, M.J. Miserendino, S. Chi, and E.J. Nestler, Fischer and Lewis rat strains show differential ocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion. J. Pharmacol. Exp. Ther. 269:137 (1994).
T.A. Kosten, M. J. Miserendino, C.N. Haile, J.L. DeCaprio, P.I. Jatlow, and E. J. Nestler, Acquisition and maintenance of intravenous cocaine self-administration in Lewis and Fischer inbred rat strains. Brain Res. 778:418 (1997).
B. Horan, M. Smith, E.L. Gardner, M. Lepore, and C.R. Ashby, Jr., (-)-Nicotine produces conditioned place preference in Lewis, but not Fischer 344 rats. Synapse 26:93 (1997).
T. Suzuki, Y. Ise, J. Maeda, and M. Misawa. Mecamylamine-precipitated nicotine-withdrawal aversion in Lewis and Fischer 344 inbred rat strains. Eur. J. Pharmacol. 369:159 (1999).
D. Beitner-Johnson, X. Guitart, and E.J. Nestler, Dopaminergic brain reward regions of Lewis and Fischer rats display different levels of tyrosine hydroxylase and other morphine-and cocaineregulated phosphoproteins, Brain Res. 561:147 (1991).
X. Guitart, D. Beitner-Johnson, D.W. Marby, T.A. Kosten, and E.J. Nestler, Fischer and Lewis rat strains differ in basal levels of neurofilament proteins and their regulation by chronic morphine in the mesolimbic dopamine system, Synapse 12:242 (1992).
P.W. Burnet, I.N. Mefford, C.C. Smith, P.W. Gold, and E.M. Sternberg, Hippocampal 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding site densities, serotonin receptor (5-HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamopituitary-adrenal axis in rat, J. Neurochem. 59:1062 (1992).
D.M. Camp, K.E. Browman, and T.E. Robinson, The effects of methamphetamine and cocaine on motor behavior and extracellular dopamine in the ventral striatum of Lewis versus Fischer 344 rats, Brain Res. 668:180 (1994).
I. Nylander, M. Vlaskovska, and L. Terenius, Brain dynorphin and enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and withdrawal, Brain Res. 683:25 (1995).
F. Chaouloff, A. Kulikov, A. Sarrieau, N. Castanon, and P. Mormede, Male Fischer 344 and Lewis rats display differences in locomotor reactivity, but not in anxiety-related behaviours: relationship with the hippocampal serotonergic system, Brain Res. 693:169 (1995).
P.W. Burnet, I.N. Mefford, C.C. Smith, P.W. Gold, and E.M. Sternberg, Hippocampal 5-HT1A receptor binding site densities, 5-HT1A receptor messenger ribonucleic acid abundance and serotonin levels parallel the activity of the hypothalamo-pituitary-adrenal axis in rats, Behav. Brain Res. 73:365 (1996).
G. Flores, G.K. Wood, D. Barbeau, R. Quirion, and L.K. Srivastava, Lewis and Fischer rats: a comparison of dopamine transporter and receptors levels, Brain Res. 814:34 (1998).
Y. Minabe, E.L. Gardner, and C.R. Ashby, Jr., Differential effects of chronic haloperidol administration on midbrain dopamine neurons in Sprague-Dawley, Fischer 344, and Lewis rats: an in vivo electrophysiological study, Synapse 29:269 (1998).
M. Werme, P. Thoren, L. Olson, and S. Brene, Addiction-prone Lewis but not Fischer rats develop compulsive running that coincides with downregulation of nerve growth factor inducible-B and neuron-derived orphan receptor 1. J. Neurosci. 19:6169 (1999).
S.E. Lindley, T.G. Bengoechea, D.L. Wong, and A..F. Schatzberg, Strain differences in mesotelencephalic dopaminergic neuronal regulation between Fischer 344 and Lewis rats. Brain Res. 832:152(1999).
J. Ortiz, J.L. DeCaprio, T.A. Kosten, and E.J. Nestler, Strain-selective effects of corticosterone on locomotor sensitization to cocaine and on levels of tyrosine hydroxylase and glucocorticoid receptor in the ventral tegmental area. Neuroscience. 67:383 (1995).
E.M. Sternberg, J.M. Hill, G.P. Chrousos, T. Kamilaris, S.J. Listwak, P.W. Gold, and R.L. Wilder, Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats, Proc. Natl. Acad. Sci. U.S.A. 86:2374 (1989).
M.R. Simar, D. Saphier, and N.E. Goeders, Dexamethasone suppression of the effects of cocaine on adrenocortical secretion in Lewis and Fischer rats, Psychoneuroendocrinology 22:141(1997).
Z. Sarnyai, E. Biro, J. Gardi, M. Vecsernyes, J. Julesz, and G. Telegdy G, Brain corticotrophin-releasing factor mediates ‘anxiety-like’ behavior induced by cocaine withdrawal in rats, Brain Res. 675:89 (1995).
F. Rodriguez de Fonseca, M. Rocío, A. Carrera, M. Navarro, G.F. Koob, and F. Weiss, Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal, Science 276:2050 (1997).
R.F. Service, Probing alcoholism’s ‘dark side’. Science 285:1473 (1999).
P. Bice, T. Foroud, R. Bo, P. Castelluccio, L. Lumeng, T.K. Li, and L.G. Carr, Genomic screen for QTLs underlying alcohol consumption in the P and NP rat lines, Mamm. Genome 9:949 (1998).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Wilder, R.L., Griffiths, M.M., Cannon, G.W., Caspi, R., Gulko, P.S., Remmers, E.F. (2002). Genetic Factors Involved in Central Nervous System/Immune Interactions. In: Friedman, H., Klein, T.W., Madden, J.J. (eds) Neuroimmune Circuits, Drugs of Abuse, and Infectious Diseases. Advances in Experimental Medicine and Biology, vol 493. Springer, Boston, MA. https://doi.org/10.1007/0-306-47611-8_7
Download citation
DOI: https://doi.org/10.1007/0-306-47611-8_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46466-9
Online ISBN: 978-0-306-47611-2
eBook Packages: Springer Book Archive